Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-06-15
1993-11-02
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142338, 5142342, 5142345, 514253, 514255, 514925, A61K 3154, A61K 31535, A61K 31495
Patent
active
052583791
ABSTRACT:
The present invention provides a method of inhibiting gastric acid secretion in mammals by administering a 5-HT1A agonist compound or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 2906757 (1959-09-01), Mills et al.
patent: 2922744 (1960-01-01), Mills et al.
patent: 3551493 (1970-12-01), Ruschig et al.
patent: 4576959 (1986-03-01), Flaugh
patent: 4745126 (1988-05-01), Leander
patent: 4818756 (1989-04-01), Seidel et al.
patent: 4845221 (1989-07-01), Stack et al.
Glennon, R. A., J. Med. Chem., 30, 1-12 (1987).
Handbook of Experimental Pharmacology, vol. XIX "5-Hydroxytryptamine and Related Indolealkylamines", Erspamer, V. sub-ed, Springer-Verlog, New York, 1966, pp. 329-335.
Bulbring, E., et al., Adv. Pharmac., 6A, 323-333 (1968).
Blundell, J. E., Neuropharmacology, 23, 1537-1551 (1984).
Arvidsson, L. E., et al., J. Med. Chem., 27, 45-51 (1984).
Naiman, N., et al., J. Med. Chem., 32, 253-256 (1989).
Arvidsson, L. E., et al, J. Med. Chem., 24, 921-923 (1981).
Middlemiss, D. N., et al., Annu. Rep. Med. Chem., 21, 41-50 (1986).
Fuller, R. W., Monogr. Neural Sci., 10, 158-181 (1984).
Taylor, E. W., et al., Mol. Pharmacol., 34, 42-53 (1988).
Nelson, W. L., et al., J. Med. Chem., 20, 880-885 (1977).
Augstein, J., et al., J. Med. Chem., 8, 446-456 (1965).
Hibert, M. T., et al., J. Med. Chem., 31, 1087-1093 (1988).
Arvidsson, L. E., et al., J. Med. Chem., 31, 92-99 (1988).
Wu. Y. H., et al., J. Med. Chem., 15, 477-479 (1972).
Yevich, J. P., et al., J. Med. Chem., l 26, 194-203 (1983).
Gharbia, M., et al., J. Med. Chem., 31, 1382-1392 (1988).
Wu, Y. H., et al., J. Med. Chem., 12, 876-881 (1969).
Glennon, R. A., et al., J. Med. Chem., 31, 867-870 (1988).
Gidda Jaswant S.
Schaus John M.
Demeter John C.
Eli Lilly and Company
Waddell Frederick E.
Weddington K.
Whitaker Leroy
LandOfFree
Method of inhibiting gastric acid secretion with n-arylpiperazin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting gastric acid secretion with n-arylpiperazin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting gastric acid secretion with n-arylpiperazin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1757600